2015
DOI: 10.3389/fendo.2015.00083
|View full text |Cite
|
Sign up to set email alerts
|

Estrogen-Related Receptors in Breast Cancer and Prostate Cancer

Abstract: Estrogen-signaling pathways are implicated in the development of breast cancer and prostate cancer. Various studies have focused on additional signaling pathways, mediated by estrogen-related receptors (ERRs). ERRs are constitutively active receptors that share a high degree of homology with the classical estrogen receptors (ERs). However, they do not bind to estrogen, while ERs do. ERRs are involved in the development of alternative pathways that lead to the development of cancer and are regarded as potential… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
45
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(48 citation statements)
references
References 84 publications
3
45
0
Order By: Relevance
“…Oestrogen‐related receptor family, a nuclear receptor super family which acts as transcription factor, has been linked to oestrogenic signals and oncogenesis . Recent data have suggested that ERRγ has very high binding affinity to BPA and acts as an in vivo receptor of BPA .…”
Section: Discussionsupporting
confidence: 80%
“…Oestrogen‐related receptor family, a nuclear receptor super family which acts as transcription factor, has been linked to oestrogenic signals and oncogenesis . Recent data have suggested that ERRγ has very high binding affinity to BPA and acts as an in vivo receptor of BPA .…”
Section: Discussionsupporting
confidence: 80%
“…It was observed that these genes are recruited to the NANOG and ESRRB chromosomal loci. No data exists regarding ESRRB expression in porcine granulosa cells in relation to cell proliferation in vitro ; however, there are several findings indicating the role of estrogen-related receptors in ovarian cancer growth, progression, and metastasis [14, 15]. Together with our results, we hypothesize that ESRRBs may reflect the function like “growth-differentiation factor,” which regulates both cellular development and transformation.…”
Section: Discussionsupporting
confidence: 74%
“…Moreover, it is estimated that there would be 161,360 new prostate cancer diagnoses and 26,730 prostate cancer-associated mortalities in 2015 (1,2). The molecular heterogeneity of prostate cancer can make its early diagnosis and treatment problematic; thus, the identification of accurate molecular biomarkers and potential therapeutic targets (at various disease stages) may result in improved patient outcome (3,4). It is therefore important to investigate the molecular mechanisms underpinning the development and progression of prostate cancer, as this may catalyze the identification of novel therapeutic targets (5,6).…”
Section: Introductionmentioning
confidence: 99%